Edition:
India

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

17.20USD
18 May 2018
Change (% chg)

$-0.10 (-0.58%)
Prev Close
$17.30
Open
$17.35
Day's High
$17.40
Day's Low
$17.20
Volume
12,212
Avg. Vol
63,593
52-wk High
$19.20
52-wk Low
$11.25

Chart for

About

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company... (more)

Overall

Beta: 2.41
Market Cap(Mil.): $484.84
Shares Outstanding(Mil.): 33.96
Dividend: 0.01
Yield (%): 0.34

Financials

BRIEF-Invacare Reports Q1 Adjusted Loss Per Share $0.35

* Q1 EARNINGS PER SHARE VIEW $-0.38 -- THOMSON REUTERS I/B/E/S

08 May 2018

BRIEF-Invacare Corp Says CEO Matthew Monaghan's 2017 Total Pay Was $8.2 Mln Vs $4.1 Mln In 2016 – SEC Filing

* INVACARE CORP SAYS CEO MATTHEW E. MONAGHAN'S 2017 TOTAL COMPENSATION WAS $8.2 MILLION VERSUS $4.1 MILLION IN 2016 – SEC FILING Source text: (https://bit.ly/2JtAzCW) Further company coverage:

09 Apr 2018

BRIEF-Invacare Says 2020 Goals Include Commitment To Achieve $100 Mln Of Annual Run-Rate EBITDA

* INVACARE - 2020 GOALS INCLUDE COMMITMENT TO ACHIEVE $100 MLN OF ANNUAL RUN-RATE EBITDA - SEC FILING Source text: (https://bit.ly/2Hlewxy) Further company coverage:

09 Apr 2018

BRIEF-Invacare Appoints Kathleen Leneghan CFO

* INVACARE APPOINTS KATHLEEN LENEGHAN CHIEF FINANCIAL OFFICER

23 Feb 2018

BRIEF-Invacare Corp Transfers Küschall Wheelchair Production From Switzerland To France

* INVACARE CORPORATION TRANSFERS KÜSCHALL WHEELCHAIR PRODUCTION FROM SWITZERLAND TO FRANCE

13 Feb 2018

BRIEF-Invacare Corp Reports Q4 Loss Per Share $0.54

* ORATION ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017

08 Feb 2018

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

06 Jan 2018

BRIEF-Invacare Announces North America Reduction In Force As Part Of Continued Cost Realignment

* INVACARE ANNOUNCES NORTH AMERICA REDUCTION IN FORCE AS PART OF CONTINUED COST REALIGNMENT

08 Dec 2017

Earnings vs. Estimates